Jasper Therapeutics (JSPR) Accumulated Expenses (2020 - 2025)
Jasper Therapeutics (JSPR) posted quarterly Accumulated Expenses of $1.6 million for Q4 2025, down 84.3% year-over-year from $10.1 million in Q4 2024, and down 84.38% quarter-over-quarter from $10.2 million in Q3 2025.
Jasper Therapeutics (JSPR) Accumulated Expenses (2020 - 2025) Analysis & Trends
Jasper Therapeutics' Accumulated Expenses history runs 6 years deep, the most recent figure standing at $1.6 million for Q4 2025.
- In Q4 2025, Accumulated Expenses fell 84.3% year-over-year to $1.6 million; the TTM figure through Dec 2025 stood at $1.6 million (down 84.3% YoY), while the FY2025 annual figure was $1.6 million, down 84.3% from the prior year.
- Accumulated Expenses for Q4 2025 stood at $1.6 million, down from $10.2 million in the prior quarter.
- The five-year high for Accumulated Expenses was $10.2 million in Q3 2025, with the low at $95000.0 in Q3 2022.
- The 5-year median for Accumulated Expenses is $3.6 million (2022), against an average of $4.1 million.
- The sharpest annual moves came in 2022 and 2023: Accumulated Expenses tumbled 98.52% in 2022, then surged 7981.05% in 2023.
- Jasper Therapeutics' Accumulated Expenses stood at $200000.0 in 2021, then surged by 2116.0% to $4.4 million in 2022, then slumped by 60.13% to $1.8 million in 2023, then jumped by 472.78% to $10.1 million in 2024, then sank by 84.3% to $1.6 million in 2025.
- Business Quant data shows JSPR's Accumulated Expenses at $1.6 million in Q4 2025, $10.2 million in Q3 2025, and $1.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Jasper Therapeutics | 20.08 Mn | 20.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.59 Mn |
| Sep 30, 2025 | 10.17 Mn |
| Jun 30, 2025 | 1.13 Mn |
| Mar 31, 2025 | 1.06 Mn |
| Dec 31, 2024 | 10.12 Mn |
| Sep 30, 2024 | 2.57 Mn |
| Jun 30, 2024 | 6.06 Mn |
| Mar 31, 2024 | 5.51 Mn |
| Dec 31, 2023 | 1.77 Mn |
| Sep 30, 2023 | 7.68 Mn |
| Jun 30, 2023 | 6.47 Mn |
| Mar 31, 2023 | 3.16 Mn |
| Dec 31, 2022 | 4.43 Mn |
| Sep 30, 2022 | 95,000.00 |
| Jun 30, 2022 | 746,000.00 |
| Mar 31, 2022 | 3.98 Mn |
| Dec 31, 2021 | 200,000.00 |
| Sep 30, 2021 | 6.42 Mn |
| Dec 31, 2020 | 2.60 Mn |